David A. Ehrmann to Antineoplastic Agents, Hormonal
This is a "connection" page, showing publications David A. Ehrmann has written about Antineoplastic Agents, Hormonal.
Connection Strength
0.135
-
Long-term suppression of testosterone after treatment with a gonadotropin-releasing hormone agonist in a woman with a presumed testosterone secreting ovarian tumor. J Clin Endocrinol Metab. 1997 Jun; 82(6):1746-8.
Score: 0.135